Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
25.75    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (1.961%)
Market Cap: £129.66m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

Portfolio Update

13 Jan 2020 07:00

RNS Number : 5133Z
Duke Royalty Limited
13 January 2020
 

13 January 2020

 

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

 

Portfolio Update

 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to update the market regarding three investments completed in December into existing portfolio companies. These investments are made in line with the Company's intended deployment of proceeds raised from the October 2019 equity issue.

 

·; Approximately £2.0 million follow-on investment into Welltel (Ireland) Limited ("Welltel"), which takes the total investment to £8.1 million. The entire facility was re-financed on Duke's typical investment terms. The proceeds were used to acquire Invistech Limited, a long established and profitable IT managed service and telecommunications business. Invistech provides strategic geographical diversification and the opportunity to cross sell to Invistech's 450 SME customer base in southern Ireland

 

·; £1.0 million follow-on investment into Trimite Global Coatings Limited ("Trimite") to support the expansion of its international operations and to conclude some legacy site rationalisation in the UK

 

·; €4.3 million follow-on investment into Temarca B.V. ("Temarca"), enabling it to acquire the only leased river cruise boat in its fleet, taking its fleet to three wholly owned vessels. A recent independent valuation conducted in November 2019 on the MS Carmen by Van Pelt and Co BV ascribed an estimated value on the vessel of €5.4 million. Duke retains a first mortgage on each of the three vessels owned by Temarca

 

Following these investments, Duke still retains approximately £31 million of additional liquidity available for new deployments, when considering existing cash resources plus the line of credit available from Honeycomb Investment Trust. This liquidity assumes a maximum of 30% loan to value in line with Duke's target maximum gearing percentage

 

 

In regard to some recent operational updates that have occurred within the Duke portfolio, Duke is pleased to announce the following highlights from some of its royalty partners:

 

·; In November 2019, Brightwater won 'Best Large Recruiter of the Year' at the 2019 National Recruitment Federation Awards in Dublin

 

·; Step Investments (via its 85% subsidiary Pearl and Dean) won back the fast-growing Everyman contract from DCM in November 2019

 

·; Welltel was a winner for the sixth consecutive year of the Deloitte "Fast-50" award in November 2019, which is an award given to the fifty fastest growing technology companies in Ireland

 

·; In December 2019, Xtremepush was awarded the Best Marketing & Services Supplier at the SBC Awards 2019 for the betting and gaming industry, held at Battersea Evolution

 

Neil Johnson, CEO of Duke, said:

 

"We enter 2020, and our last fiscal quarter, with enhanced monthly cashflows from a diversified portfolio which provides Duke shareholders with exposure to 19 underlying profitable companies. As these follow-on investments demonstrate, we are long-term partners to our companies, an approach which in turn provides Duke shareholders with the opportunity to participate in the growth of a diverse range of private companies. Helping existing Royalty Partners to acquire other businesses or hard assets enhances the underlying diversification and security of our revenue stream.

 

"We have significant means for further royalty investments to deploy against our pipeline of opportunities, and we look forward to updating the market in due course."

 

As at 31 December 2019, the portfolio breakdown was as follows:

 

Royalty Partner

Total Investment Amount

Date of Initial Investment

Temarca B.V.

€14,052,000

April 2017

Berkley Recruitment (Group) Limited

€1,300,000

June 2017

Welltel (Ireland) Limited

£8,127,000

June 2017

Lynx Equity (UK) Limited

£12,000,000

October 2017

Xtremepush Limited

£2,000,000

February 2018

Trimite Global Coatings Limited

£11,000,000

March 2018

United Glass Group Ltd

£7,500,000

April 2018

Step Investments Limited

£3,000,000

June 2018

BHPC Limited

€4,600,000

August 2018

InterHealth Canada

£10,000,000

August 2018

Brightwater Selection (Ireland) Limited

€1,875,000

September 2018

MRDB Holdings Limited Group

£10,000,000

February 2019

 

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

+44 (0) 1481 741 240

Cenkos Securities plc 

(Nominated Adviser and Broker)

Julian Morse / Michael Johnson / Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

Newgate Communications

(PR)

Elisabeth Cowell / Ian Silvera / Megan Kovach

+44 (0) 20 3757 6882

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUMZGMMLZLGGZG
Date   Source Headline
28th May 20267:00 amRNSNotice of Results & Investor Presentation
31st Mar 20267:00 amRNSTrading and Operational Update
19th Mar 20267:00 amRNSInterim Dividend and Dividend Declaration
26th Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
18th Dec 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Dec 20257:00 amRNSInterim Financial Results
17th Oct 20257:00 amRNSFollow-On Investment into Step Investments Limited
1st Oct 20257:00 amRNSFollow-On Investment into Integrum Group Holdings
29th Sep 20257:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Aug 202511:17 amRNSResult of Annual General Meeting
1st Aug 20258:08 amRNSDirector/PDMR Dealings
11th Jul 20257:00 amRNSAnnual Report & Notice of Annual General Meeting
25th Jun 20257:00 amRNSFinal Results for the year ended 31 March 2025
19th Jun 20257:00 amRNSInterim Dividend and Dividend Declaration
2nd Jun 20257:00 amRNSFollow-On Investment into Existing Capital Partner
27th May 20257:00 amRNSNotice of Results & Investor Presentation
2nd Apr 20257:00 amRNSFollow-On Investment into Existing Capital Partner
31st Mar 20257:00 amRNSTrading and Operational Update
20th Mar 20257:00 amRNSInterim Dividend and Dividend Declaration
19th Feb 20257:00 amRNSFollow-On Investment into BPVA (Ireland) Limited
30th Dec 20247:00 amRNSTrading and Operational Update
17th Dec 202412:50 pmRNSInterim Dividend and Dividend Declaration
16th Dec 20247:00 amRNSInterim Results for the six months ended 30 Sep 24
4th Dec 20249:40 amRNSDirector/PDMR Shareholding
3rd Dec 202411:34 amRNSResult of General Meeting and Issue of Equity
22nd Nov 20243:38 pmRNSResult of Retail Offer and Broker Option
15th Nov 20247:00 amRNSResult of Placing
14th Nov 20245:02 pmRNSRetail Offer to raise up to £3.0 million
14th Nov 20245:01 pmRNSIssue of Equity
30th Sep 20247:00 amRNSTrading and Operational Update
19th Sep 20247:00 amRNSInterim Dividend and Dividend Declaration
3rd Sep 20247:00 amRNSFollow-On Investment into United Glass Group
1st Aug 20243:16 pmRNSDirector/PDMR Dealings
1st Aug 202411:40 amRNSResult of Annual General Meeting
22nd Jul 20247:00 amRNSFollow-On Investment into Step Investments Limited
15th Jul 20247:00 amRNSAnnual Report & Notice of Annual General Meeting
27th Jun 20247:00 amRNSFinal Results for the year ended 31 March 2024
20th Jun 202411:50 amRNSInterim Dividend and Dividend Declaration
3rd Jun 20247:00 amRNSNotice of Results
17th May 202411:45 amEQSHardman & Co Q&A on Duke Capital (DUKE) | Generating investor returns by uniquely meeting customer needs
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.